Blog - Page 3417 of 5493

MondayDec 20, 2010 2:46 pm

Pernix Therapeutics Holdings, Inc. (PTX) Forms Joint Venture with SEEK to Develop Cough Treatment

Pernix Therapeutics Holdings Inc., an integrated specialty pharmaceutical company focused primarily on the pediatric market, today announced its new joint venture with SEEK, a leading UK private drug discovery group. The companies have licensed or assigned all of their relative intellectual property to the joint venture to undertake the late-stage development and registration of BC1036, a first-in-class drug designed to address the serious need for a safer and more effective, non-opioid treatment for persistent cough. According to today’s announcement, persistent cough is a very common condition, though the cough market has seen little to no innovation over the past 20…

MondayDec 20, 2010 2:34 pm

Synthesis Energy Systems Inc. (SYMX) Completes Gasification Testing, Moves toward Licensing Agreement

Synthesis Energy Systems Inc., a global energy and gasification technology company, today announced it has completed a commercial-scale demonstration test in which more than 2,000 tons of high ash coal from Queensland, Australia were gasified at its Zao Zhuang plant in Shandong Province, China. Synthesis Energy conducted the test in response to the significant interest it has received from Ambre Energy of Australia, which has plans to build a coal-to-gasoline/LPG plant with a capacity of 18,000 barrels per day. During the test, Synthesis Energy efficiently processed Ambre's low-to-medium rank, 42.6% ash content coal. Synthesis said the syngas produced during the…

MondayDec 20, 2010 2:32 pm

EarthLink, Inc. (ELNK) Moves to Acquire One Comm, Adjusts Quarterly Dividend Rate

EarthLink, www.earthlink.net – the widely-known IP infrastructure and services provider, reported a definitive merger agreement to acquire integrated telecom firm, One Communications Corp. ("One Comm"), for $370M. Chairman and CEO of ELNK, Rolla P. Huff, called the acquisition a dominant play which scoops up the infrastructure of One Comm, a dominant force in the market across much of the Eastern US and integrates it into the newly formed EarthLink Business division. The merger, which was approved by the Board of Directors of each company, as well as One Comm’s stockholders, puts ELNK in control of a massive nationwide IP network…

MondayDec 20, 2010 11:47 am

BrainStorm Cell Therapeutics, Inc. (BCLI.OB) Gets Funding for Its Adult Stem Cell Technology

BrainStorm Cell Therapeutics Inc. is a leading developer of adult stem cell therapeutic products. The company holds the global rights to develop and commercialize its core technology – NurOwn – which was developed at Israel's Tel-Aviv University. The NurOwn technology processes adult human mesenchymal stem cells that are present in bone marrow. These cells are capable of self-renewal as well as differentiation into many other cell types. The technology is highly attractive for treating spinal cord injuries, multiple sclerosis, Parkinson's disease and ALS – Amyotrophic lateral sclerosis, which is widely known as Lou Gehrig's disease. The company announced today that…

MondayDec 20, 2010 10:11 am

Fibrocell Science (FCSC.OB) Meets All FDA Requirements for Skin Treatment Product

Fibrocell Science Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, today announced it has submitted its complete response to the U.S. Food and Drug Administration’s (FDA) concerning the company’s Biologics License Application for azficel-T. Submitting the response brings the company into full compliance with the FDA in regards to azficel-T, proposed brand name laViv®, for the treatment of moderate to severe nasolabial folds and winkles. “The submission of our response to the FDA is a significant milestone for our lead cell therapy, azficel-T,” David Pernock, Fibrocell Science chairman and CEO…

MondayDec 20, 2010 9:59 am

Plug Power Inc. (PLUG) Video Chart for Monday, December 20, 2010

PLUG is back down to a support level that it has held for many months. This is the third time in the last nine months that it has held this level and it has produced significant bounces the last two times, so it is on radar to hold support and possibly make another climb. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts.php Let us hear your thoughts below:

MondayDec 20, 2010 9:57 am

Universal Detection Technology (UNDT.OB) Enters Brazilian Distribution Agreement

Located in Los Angeles, California, Universal Detection Technology has earned a stellar reputation as a developer of threat monitoring technologies, which include bioterrorism detection devices. Today, UNDT took another step forward by entering into a distribution agreement with the Brazil-based ORMAX Tecnologia em Seguranca. The San Paulo based ORMAX specializes in all aspects of safety and security business, residential, perimeter, personnel, intelligence and counterintelligence products. ORMAX and UNDT today announced that ORMAX will distribute UNDT’s Biological, Chemical and Radiation Detection Equipment in Brazil, which has been named the site for the 2014 World Cup and 2016 Summer Olympics. UNDT’s biodetection…

MondayDec 20, 2010 9:08 am

Gran Tierra Energy Inc. (GTE) Issues 2011 Oil and Gas Budget

Gran Tierra Energy Inc. announced the company will spend $299.2 million in 2011 on its oil and gas program. The funds will be used for exploration and development on the company’s properties in South America, including Colombia, Peru, Argentina and Brazil. Gran Tierra Energy Inc. plans to spend $146.9 million on drilling and completion of oil and gas wells. This capital will cover the drilling of twenty one wells during 2011. The company has allocated the majority of this capital for its program in Colombia, where it plans ten wells in 2011. Gran Tierra Energy Inc. also plans to drill…

MondayDec 20, 2010 9:01 am

Fero Industries, Inc. (FROI.OB) Ships the First Delivery of 20,000 Retail Packages of Sucanon® to Merck S.A. de C.V.

Fero Industries, Inc. announced that they processed and shipped the first delivery of 20,000 retail packages of Sucanon® to Merck S.A. de C.V. for distribution in Mexico. The initial shipment of 20,000 retail packages represents the minimum monthly purchase commitment from Merck S.A. de C.V. for the Mexico market. Each retail package of 60 tablets is the equivalent of a one-month patient supply. Upon receipt of the initial delivery, Merck S.A. de C.V. doubled their scheduled order. Merck requested that the Company deliver an additional 20,000 retail packages prior to the end of this month. Sucanon® is one of only…

MondayDec 20, 2010 8:59 am

RXi Pharmaceuticals Corp. (RXII) Announces Product Candidate to Reduce Surgical Scarring

RXi Pharmaceuticals Corp., a leader in RNAi-based therapeutic discovery and development, recently announced RXI-109 as its first RNAi therapeutic product candidate to advance into development. RXI–109 is a self-delivering RNAi compound designed to reduce dermal scarring in planned surgeries. The company notes scar prevention and reduction as an unmet therapeutic medical need with a potential market of up to $4 billion a year. Anti-scarring, or anti-fibrotic treatments, are being developed to not only address the cosmetic issues of scarring, but also to treat other medical conditions where excess scarring and/or fibrosis may occur, and might possibly be painful. “Dermal anti-scarring…

Site Search

Company Search